How to Research a Stock: The Complete Guide

Every stock pitch you will ever hear is an answer to three questions: Is this a healthy business? Is it getting better or worse? And what is it worth? Professional analysts at the big desks and the great investors in the classic books — Benjamin Graham, Peter Lynch, Philip Fisher — disagree on style, but they all work through those same three questions, in roughly that order. This guide walks the whole path: where the information lives on the internet (almost all of it free), how to read what you find, which numbers actually measure health, how valuation works without a PhD, and the red flags that have preceded most blow-ups. It is long on purpose. Bookmark it, and work through it with a real company open in another tab.

One ground rule before we start, straight from Graham: you are researching a business, not a ticker. A stock is a fractional claim on a company’s future cash flows. If a piece of information would not matter to someone buying the whole company, it probably should not drive your decision either.

Part 1 — Where everything lives on the internet

The single biggest unlock for a new investor is realizing that the primary sources — the documents companies are legally required to file, signed by their executives under penalty — are free. You do not need a Bloomberg terminal to read what BlackRock reads. You need to know six websites.

SEC EDGAR: the primary source for everything

Every U.S. public company files its reports with the Securities and Exchange Commission, and EDGAR publishes them within seconds. The filings that matter most:

• 10-K — the annual report. The full story of the business: what it sells, what could kill it, audited financials. The one document to read before owning any stock.
• 10-Q — the quarterly update. Unaudited financials and a shorter discussion of the quarter.
• 8-K— “material events,” filed within days: CEO departures, acquisitions, guidance changes, auditor changes. Reading a year of 8-Ks tells you how eventful (or chaotic) a company’s life is.
• DEF 14A (the proxy) — executive pay, board composition, related-party transactions, and shareholder votes. If management is quietly enriching itself, the evidence is here.
• Form 4 — insider trades, filed within two business days. Officers and directors must report every buy and sell.
• 13F — quarterly holdings of large institutional managers. How you check what Berkshire, Citadel, or any big fund actually held (45 days delayed).

Two power tools most people never find: EDGAR full-text search lets you search phrases like “going concern” or “material weakness” across every filing ever made, and each filing page offers the financial statements as structured data.

The rest of the free stack

A useful habit from the professional side: for any company, open the IR page and EDGAR side by side. The IR page is marketing — polished decks and highlight reels. EDGAR is the law — risk factors and audited numbers. The distance between the two tones is itself information.

Part 2 — Reading the three financial statements

Every 10-K contains three statements. Each answers a different question, and each can be faked in a different way — which is why you read all three together.

The income statement: is the business profitable?

Revenue at the top, profit at the bottom, costs in between. Watch the staircase: revenue → gross profit (after the direct cost of the product) → operating income (after salaries, rent, R&D, marketing) → net income (after interest and tax). Each step down tells you where the money goes. A company with 60% gross margins but 3% operating margins is spending violently on something — find out what, and whether it is an investment or a treadmill.

The balance sheet: can it survive a bad year?

A snapshot of what the company owns (assets) and owes (liabilities). The tests here are about survival: cash versus short-term obligations, total debt versus the profits available to service it. Companies rarely die of a bad quarter; they die because debt came due at the wrong moment.

The cash flow statement: is the profit real?

Net income is an opinion — accrual accounting involves estimates. Cash is a fact. Operating cash flow shows the money that actually arrived; capital expenditures show what had to be reinvested; free cash flow (operations minus capex) is what the business truly generated for its owners. The classic warning sign is profit that grows for years while operating cash flow does not — that gap is where frauds and fantasies live.

Part 3 — The health check: numbers that matter

You can compute all of these from the statements, and screeners compute them for you. Ranges below are rules of thumb — always compare against the company’s own industry, because a healthy software margin and a healthy grocery margin are different worlds.

Two habits multiply the value of every ratio. First, trend beats level: five years of gross margin tells you more than this year’s. Second, cross-check pairs: revenue growing 30% while receivables grow 60% means the company is booking sales faster than customers are paying — sometimes seasonal, sometimes the first chapter of a disaster.

Part 4 — Growth and the moat

A healthy business at a fair price still needs a reason to be worth more later. That is growth — and the durability of growth is the moat, Warren Buffett’s term for whatever stops competitors from eating the returns. Moats come in a handful of documented flavors: brands people pay up for, network effects that make the product better as it grows, switching costs that lock customers in, cost advantages from scale, and licenses or patents that legally exclude rivals. When you read the 10-K’s Business section, you are hunting for which of these — if any — the company actually has, and whether the margin history backs the story up. A real moat shows up in the numbers as margins and returns on capital that stay high for years while competitors’ do not.

Measure growth with a compounted rate, not a single year: the CAGR calculator turns “revenue went from $2.1B to $4.8B in five years” into an honest 18%-a-year figure you can compare across companies.

Part 5 — Valuation: what is it worth?

“Price is what you pay; value is what you get.” A wonderful company can be a terrible stock at the wrong price. The professional toolkit sounds intimidating but rests on one idea: a business is worth the cash it will hand its owners, discounted for the waiting and the risk.

• P/E (price ÷ earnings) — how many years of current profit you pay upfront. Useful for stable earners; meaningless for money-losers and cyclicals at peak earnings.
• EV/EBITDA— the acquirer’s lens: whole-company value (including debt) against pre-interest profits. Better than P/E when comparing firms with different debt loads.
• P/FCF (price ÷ free cash flow) — the hardest ratio to fake, because it is built on cash.
• PEG (P/E ÷ growth)— Lynch’s shortcut for weighing a rich multiple against fast growth; near 1 is his benchmark of fair.
• Dividend yield — for income stocks: cash paid ÷ price, checked against whether free cash flow covers the dividend.

The full-strength version is the discounted cash flow (DCF): project free cash flows, discount them back at a required return (present value is exactly this operation). The honest truth even professionals admit: a DCF is precisely wrong — tiny assumption changes swing the answer wildly. Its real value is forcing you to write your assumptions down. That is why Graham’s margin of safety remains the master rule: only buy when your estimate of value exceeds the price by enough that being somewhat wrong still works out.

Practical calibration: pull the company’s own five-year range of P/E and EV/EBITDA and its closest three competitors’ multiples. “Cheap versus its own history and its peers, with health intact” is a far stronger statement than cheap in the abstract.

Part 6 — Red flags: the pre-mortem checklist

Most catastrophic stock losses announce themselves in the filings first. Search these before you buy (EDGAR full-text search does it in seconds):

• “Going concern” language — the auditor doubts survival over the next year.
• “Material weakness” in internal controls — the numbers themselves may not be reliable.
• Auditor changes or resignations — especially from a big firm to a small one.
• Restatements of prior financials.
• Receivables or inventory growing much faster than revenue — channel stuffing and demand problems hide here.
• Serial “adjusted” profits — a company that is only profitable after excluding real, recurring costs, year after year.
• Relentless share dilution — check share count over five years; your slice of the pie may be shrinking faster than the pie grows.
• Clustered insider selling on Form 4s, or related-party deals in the proxy.
• Promotion-heavy management — more press releases than filings is a cultural tell.

Part 7 — A one-hour research workflow

1. 10 min — Business section of the latest 10-K.Can you explain what they sell, to whom, and why customers stay, in two sentences? (Lynch: if you can’t, pass.)
2. 10 min — Five-year numbers. Revenue CAGR, gross and operating margin trend, free cash flow, share count, debt.
3. 10 min — Risk factors + full-text red-flag search. Skim Item 1A for the risks specific to this company (ignore boilerplate), then search the red-flag phrases above.
4. 10 min — The proxy and Form 4s. How is management paid, and are insiders buying or selling?
5. 10 min — Latest earnings call.Listen to the Q&A half — analysts’ questions reveal the controversy; management dodges reveal the weak spots.
6. 10 min — Valuation snapshot.P/E, EV/EBITDA, and P/FCF against the company’s own five-year range and three peers. Write one paragraph: what you must believe for this price to be cheap.

Then — and only then — decide how much to buy, which is a position-sizing question, not a conviction question.

The bookshelf behind this guide

• Benjamin Graham, The Intelligent Investor — margin of safety and Mr. Market.
• Peter Lynch, One Up on Wall Street — invest in what you understand; the six stock categories.
• Philip Fisher, Common Stocks and Uncommon Profits— the “scuttlebutt” method of primary research.
• Pat Dorsey, The Little Book That Builds Wealth — the moat taxonomy used above.
• Howard Schilit, Financial Shenanigans — the red-flag catalogue, case by case.

None of this predicts next quarter’s price, and none of it is a recommendation to buy anything. What it does is move you from opinions about tickers to judgments about businesses — which is the entire difference between speculating and investing.